Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry for patients referred to cardio-oncology

Official title: Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée

Run by European Georges Pompidou Hospital · NCT04407780 · Data updated 2026-11-12

This study is collecting information from cancer patients who are referred for heart health checks to see how cancer treatments might affect their hearts.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorEuropean Georges Pompidou Hospital
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedJanuary 1, 2017
Main results expectedJune 1, 2022
Study endsJune 1, 2027
Registry record updatedMay 29, 2020
Trial IDNCT04407780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are patients who have been referred for cardio-oncology assessment due to their cancer treatment.

Probably not a fit

Patients who refuse to participate in the registry will not benefit from the data collection and insights generated.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to gather data on patients referred for cardio-oncology assessment, focusing on the intersection of cancer and heart health. By collecting prospective data, the study seeks to provide a clearer understanding of cardiotoxicity associated with cancer treatments and to identify early signals of heart-related issues in cancer patients. The registry will also support ancillary projects targeting specific cancer types and treatment regimens. The goal is to enhance the knowledge base in the emerging field of cardio-oncology.

Why it matters

Potential benefit: If successful, this registry could lead to improved monitoring and management of heart health in cancer patients, potentially reducing the risk of cardiotoxicity.

How similar studies have gone: While the field of cardio-oncology is emerging, similar registries have shown promise in enhancing understanding of the relationship between cancer treatments and cardiovascular health.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* referred to cardio-oncology

Exclusion Criteria:

* refusal to participate

Where it's running

  • Assistance Publique Hôpitaux de Paris - Centre Université de Paris
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.